TickerFiles

BIOLARGO, INC. 10-Q filing

Filed 2025-08-14 · Report date 2025-06-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001437749-25-027021
Form type
10-Q
CIK
0000880242
Primary document
https://www.sec.gov/Archives/edgar/data/880242/000143774925027021/blgo20250630_10q.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for BIOLARGO, INC..

Reported financial metrics

MetricCurrentPriorChange
Cost Of Revenue$3.1M--
Gross Profit$2.9M--
Operating Income$-3.7M--
Eps Basic-0.008--
Cash And Equivalents$3.5M--
Total Assets$12.5M--
Total Liabilities$6.4M--
Shareholders Equity$8.8M--
Operating Cash Flow$-3.9M--